Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
Holding ADPT?
Track your performance easily

Adaptive Biotechnologies (ADPT) Ownership - Who Owns Adaptive Biotechnologies?

856 Followers

Adaptive Biotechnologies (ADPT) Ownership Overview

4.18%13.36%19.56%19.62%43.27%
19.56% Other Institutional Investors
19.62% ETFs
43.27% Public Companies and
Individual Investors
The ownership structure of Adaptive Biotechnologies (ADPT) stock is a mix of institutional, retail, and individual investors. Approximately 52.55% of the company’s stock is owned by Institutional Investors, 4.18% is owned by Insiders, and 43.27% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$444684
Jun 30, 2024
xxxxxxxxxxxxx
$41311440

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
29,993,708Institution20.32%194,659,165
11,601,134Institution7.86%75,291,360
11,572,590Institution7.84%75,106,109
11,178,516Institution7.57%72,548,569
9,647,309Institution6.54%62,611,035
8,375,660Institution5.68%54,358,033
6,018,945Institution4.08%39,062,953
2,576,701Insider1.75%16,722,789
1,680,157Institution1.14%10,904,219
1,304,731Institution0.88%8,467,704

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
8,375,660Institution5.68%54,358,033
1,680,157Institution1.14%10,904,219
1,304,731Institution0.88%8,467,704
1,136,439Institution0.77%7,375,489
816,757Institution0.55%5,300,753
736,555Institution0.50%4,780,242
655,833Institution0.44%4,256,356
558,473Institution0.38%3,624,490
524,781Institution0.36%3,405,829
484,990Institution0.33%3,147,585

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
11,200,654Institution7.59%72,692,244
4,191,669Institution2.84%21,461,345
3,183,129Institution2.16%20,658,507
1,770,807Institution1.20%9,066,532
1,755,907Institution1.19%8,990,244
1,100,645Institution0.75%7,143,186
992,527Institution0.67%6,441,500
967,069Institution0.66%4,951,393
535,738Institution0.36%3,117,995
530,753Institution0.36%2,717,455

FAQ

Who Owns Adaptive Biotechnologies Corp (ADPT)?
According to the latest TipRanks data, approximately 19.56% of the company's stock is held by institutional investors, 4.18% is held by insiders, and 43.27% is held by retail investors.
    What percentage of Adaptive Biotechnologies Corp (ADPT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 19.56% of Adaptive Biotechnologies Corp (ADPT) stock is held by institutional investors.
      What percentage of Adaptive Biotechnologies Corp (ADPT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 43.27% of Adaptive Biotechnologies Corp (ADPT) stock is held by retail investors.
        Who owns the most shares of Adaptive Biotechnologies Corp (ADPT)?
        Andreas Halvorsen owns the most shares of Adaptive Biotechnologies Corp (ADPT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis